Burosumab

Burosumab (KRN23) is a human monoclonal antibody targeting fibroblast growth factor 23 (FGF23) for the treatment of cutaneous-skeletal hypophosphatemic syndrome (CSHS) and tumor-induced osteochondrosis.

Product Specifications

CAS Number

1610833-03-8

Stability

≥ 2 years

Purity

>98% (HPLC)

Molecular Formula

——

Notes

Research use only, not for human use.

Receptor

Others

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP2-41121V 0.1 mL

Chicken Polyclonal FAM82A Antibody [DyLight 405]

Ask

View Details

GTR15102864 1 Vial

Lentiviral mouse Ccpg1os shRNA (UAS) - Lentiviral mouse Ccpg1os shRNA (UAS, RFP) (100)

Ask

View Details

46858111 3x 1.0 µg

TMEM105 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

Ask

View Details

STJ502988 100 µg

Anti-SLC5A1 Antibody

Ask

View Details